Replies to post #72586 on Biotech Values

[exwannabe]

Re: Pg 36, Dyax, FDA AC's in general

"The application supports the efficacy of ecallantide ..."

Interesting, I honestly missed this on my first pass.

What puzzles me is the clear difference between the "Clinical Briefing Document" you are citing and the "Statistical Review and Evaluation" document located about 4/5ths down in the document that I was focused on.

I guess this makes it very likely to get a thumbs up by a vote of X-2, with the stat guy and some random person dissenting.